Lv6
1948 积分 2023-08-02 加入
Leukemic stem cell subtypes determine venetoclax resistance and therapeutic vulnerabilities in AML
12小时前
已完结
Measurable residual disease intervention in AML: a new therapeutic horizon
8天前
已完结
Measurable residual disease intervention in AML: a new therapeutic horizon
22天前
已关闭
Sialylated CD43 forms a glyco-immune barrier that restrains antileukemic immunity
23天前
已完结
Fusion gene depletion eliminates stemness and induces bidirectional differentiation of acute myeloid leukemia
24天前
已完结
Minimal residual disease monitoring by quantitative RT-PCR in core binding factor AML allows risk stratification and predicts relapse: results of the United Kingdom MRC AML-15 trial
24天前
已完结
Measurable residual disease monitoring in acute myeloid leukemia with t(8;21)(q22;q22.1): results from the AML Study Group
24天前
已完结
Somatic mutational landscape of AML with inv(16) or t(8;21) identifies patterns of clonal evolution in relapse leukemia
24天前
已完结
Tracing the origins of relapse in acute myeloid leukaemia to stem cells
24天前
已完结
Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell
24天前
已完结
皖公网安备34019202002308
